Total Payments
$5,813
2024 Payments
$3,370
Companies
20
Transactions
95
Medicare Patients
21,851
Medicare Billing
$14.2M
Payment Breakdown by Category
Food & Beverage$3,509 (60.4%)
Travel$2,304 (39.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,509 | 92 | 60.4% |
| Travel and Lodging | $2,304 | 3 | 39.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $1,661 | 6 | $0 (2024) |
| Dutch Ophthalmic, USA | $927.58 | 2 | $0 (2024) |
| Genentech, Inc. | $415.08 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $414.63 | 12 | $0 (2024) |
| ABBVIE INC. | $359.31 | 11 | $0 (2024) |
| Genentech USA, Inc. | $299.92 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $258.69 | 8 | $0 (2024) |
| NotalVision | $225.37 | 2 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $206.34 | 4 | $0 (2024) |
| RxSight Inc | $151.13 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,370 | 30 | EyePoint Pharmaceuticals US, Inc. ($1,585) |
| 2023 | $840.95 | 22 | Apellis Pharmaceuticals, Inc. ($171.58) |
| 2022 | $741.17 | 20 | Genentech, Inc. ($295.30) |
| 2021 | $123.36 | 5 | Novartis Pharmaceuticals Corporation ($64.89) |
| 2020 | $156.01 | 3 | Alcon Vision LLC ($119.76) |
| 2019 | $89.82 | 5 | Novartis Pharmaceuticals Corporation ($47.59) |
| 2018 | $300.55 | 4 | NotalVision ($223.29) |
| 2017 | $191.69 | 6 | Alcon Laboratories Inc ($100.51) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/16/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Travel and Lodging | In-kind items and services | $839.68 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Ophthalmology | ||||||
| 11/08/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Ophthalmology | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $1,055.97 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $121.19 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/25/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/10/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/01/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $36.90 | General |
| 09/06/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: EYE CARE | ||||||
| 06/04/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $111.27 | General |
| Category: EYE CARE | ||||||
| 05/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: EYE CARE | ||||||
| 05/17/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Ophthalmology | ||||||
| 05/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: Ophthalmology | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Ophthalmology | ||||||
| 04/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Ophthalmology | ||||||
| 02/28/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 5,571 | 39,295 | $18.0M | $4.2M |
| 2022 | 16 | 5,369 | 20,251 | $12.0M | $3.5M |
| 2021 | 17 | 5,687 | 20,690 | $9.0M | $3.4M |
| 2020 | 21 | 5,224 | 18,423 | $6.0M | $3.0M |
Total Patients
21,851
Total Services
98,659
Medicare Billing
$14.2M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 227 | 2,658 | $6.6M | $1.8M | 27.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 72 | 21,000 | $2.6M | $607,198 | 23.1% |
| J3590 | Unclassified biologics | Office | 2023 | 125 | 202 | $1.5M | $481,181 | 32.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,302 | 3,646 | $1.3M | $358,719 | 26.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 96 | 1,890 | $1.9M | $353,852 | 18.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 367 | 2,237 | $1.3M | $220,091 | 17.0% |
| 92134 | Imaging of retina | Office | 2023 | 1,345 | 3,654 | $1.6M | $122,591 | 7.5% |
| J3490 | Unclassified drugs | Office | 2023 | 15 | 38 | $210,900 | $67,133 | 31.8% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 24 | 175 | $175,000 | $37,516 | 21.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 987 | 2,384 | $274,160 | $30,278 | 11.0% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 13 | 240 | $88,001 | $28,887 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 164 | 164 | $77,080 | $20,564 | 26.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 116 | 123 | $45,879 | $13,520 | 29.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 450 | 512 | $64,000 | $10,118 | 15.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 30 | 90 | $63,632 | $6,376 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 69 | $24,978 | $6,320 | 25.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 42 | 42 | $18,102 | $5,062 | 28.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 18 | $22,032 | $3,589 | 16.3% |
| 92250 | Photography of the retina | Office | 2023 | 77 | 87 | $16,878 | $2,731 | 16.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 13 | 32 | $20,992 | $1,688 | 8.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 24 | 34 | $8,942 | $1,245 | 13.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 190 | 2,350 | $4.4M | $1.7M | 37.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 118 | 4,705 | $3.7M | $1.0M | 28.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,221 | 3,191 | $923,222 | $317,494 | 34.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 367 | 2,266 | $1.3M | $221,536 | 17.5% |
About Dr. Alexander Melamud, MD
Dr. Alexander Melamud, MD is a Ophthalmology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669573788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Melamud, MD has received a total of $5,813 in payments from pharmaceutical and medical device companies, with $3,370 received in 2024. These payments were reported across 95 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,509).
As a Medicare-enrolled provider, Melamud has provided services to 21,851 Medicare beneficiaries, totaling 98,659 services with total Medicare billing of $14.2M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Fairfax, VA
- Active Since 09/25/2006
- Last Updated 11/14/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1669573788
Products in Payments
- EYP-1901 (Drug) $1,585
- EVA, combined machine (Device) $927.58
- OZURDEX (Drug) $488.38
- ForeseeHome (Device) $225.37
- EYLEA HD (Biological) $223.83
- ReSTOR (Device) $220.27
- Vabysmo (Drug) $212.76
- Syfovre (Drug) $206.34
- SUSVIMO (Drug) $196.07
- Izervay (Drug) $181.16
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $151.13
- BEOVU (Drug) $148.73
- MiSight Contact Lens (Device) $143.27
- VABYSMO (Drug) $125.00
- EYLEA (Biological) $122.90
- Lucentis (Biological) $108.44
- Cimerli (Biological) $86.94
- YUTIQ (Drug) $73.21
- EYLEA AFLIBERCEPT INJECTION (Biological) $67.90
- XIPERE (Drug) $58.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Fairfax
John Josephson, M.d, M.D
Ophthalmology — Payments: $10,226
Ophthalmology $10,226
Dr. John Baldinger, M.d, M.D
Ophthalmology — Payments: $9,473
Ophthalmology $9,473
Linda Dressler, Md, MD
Ophthalmology — Payments: $4,055
Ophthalmology $4,055
Daniel Geller, Md, MD
Ophthalmology — Payments: $4,028
Ophthalmology $4,028
Erin Ong, M.d/M.s, M.D/M.S
Ophthalmology — Payments: $3,161
Ophthalmology $3,161
Dr. Kristen Dunbar, Md, MD
Ophthalmology — Payments: $2,711
Ophthalmology $2,711